Expert Review of Proteomics

Papers
(The median citation count of Expert Review of Proteomics is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
The path to anti-vector vaccines: current advances and limitations in proteomics and bioinformatics80
How can proteomics help solve the lack of biomarkers to aid in the early diagnosis of motor neuron disease (MND)?55
Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease38
Proteomic profiling and network biology of colorectal cancer liver metastasis22
24th Human Proteome Organization World Congress; Results from the Early Career Researcher Manuscript Competition announcement19
Cutaneous leishmaniasis: multiomics approaches to unravel the role of immune cells checkpoints18
Oncoproteomic profiling of AML: moving beyond genomics18
The interdependence of machine learning and LC-MS approaches for an unbiased understanding of the cellular immunopeptidome17
Mapping the human brain proteome: opportunities, challenges, and clinical potential16
Omics and rare diseases: challenges, applications, and future perspectives16
The method developer’s guide to oligonucleotide design14
Positional proteomics: is the technology ready to study clinical cohorts?13
LC-MS/MS: A sensitive and selective analytical technique to detect COVID-19 protein biomarkers in the early disease stage11
Proteomic tools to study phosphorylation of intrinsically disordered proteins10
Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detection10
A computational method for the prediction and functional analysis of potential Mycobacterium tuberculosis adhesin-related proteins10
Utilizing databases for astrocyte secretome research10
Optimization of glycopeptide enrichment techniques for the identification of clinical biomarkers9
Proteomic profiling of cerebrospinal fluid reveals pathophysiology changes and diversity of treatment response in pediatric Streptococcus pneumoniae meningitis8
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology8
Proteogenomic profiling of acute myeloid leukemia to identify therapeutic targets8
Role of structural disorder in the multi-functionality of flavivirus proteins7
Unravelling disease complexity: integrative analysis of multi-omic data in clinical research7
Recent advances in mass spectrometry for the detection of doping7
How to maximize power for differential expression analysis in discovery omics through experimental design6
Analyzing the glial proteome in Alzheimer’s disease6
A Galaxy of informatics resources for MS-based proteomics6
Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson’s disease6
Proteomic interrogation of the human olfactory system: the road ahead6
Mass spectrometry (MS)-based proteomics and the sulfome: clinical potential6
Rebellion of the deregulated regulators: What is the clinical relevance of studying intrinsically disordered proteins?6
T cell population size control by coronin 1 uncovered: from a spot identified by two-dimensional gel electrophoresis to quantitative proteomics6
Extracellular vesicle proteomics in brain solid tumors: future strategy for personalized medicine5
Salivary metabolomics in early detection of oral squamous cell carcinoma – a meta-analysis5
Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies5
Advances in the clinical use of metaproteomics5
Revisiting the antigen markers of vector-borne parasitic diseases identified by immunomics: identification and application to disease control5
Tackling reproducibility: lessons for the proteomics community5
The use of urine peptidomics to define dietary gluten peptides from patients with celiac disease and the clinical relevance5
The evolution of analytical techniques for multiplex analysis of protein biomarkers5
How glycomic studies can impact on prostate cancer5
Glycosylation in cancer as a source of biomarkers5
Proteomic profiling of oral squamous cell carcinoma tissues reveals altered immune-related proteins: implications for personalized therapy4
The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease4
Integrative analysis of proteomic and MRI data reveals protein associations with brain imaging features in Alzheimer’s disease4
Neuroproteomic mapping of kinases and their substrates downstream of acetylcholine: finding and implications4
Patient-responsive protein biomarkers for cartilage degeneration and repair identified in the infrapatellar fat pad4
Evaluation of a ‘plug and play’ nanoflow liquid chromatography system for MS-based proteomic characterization of clinical FFPE specimens4
Urine proteomics in cardiovascular disease: advances in biomarker discovery and clinical applications4
Recent implementations of data-independent acquisition for cancer biomarker discovery in biological fluids4
VDAC1: at the crossroads of cancer signalling and metabolism4
Interaction and regulation of the mitochondrial proteome – in health and disease4
Metabolomics in diabetes mellitus: clinical insight4
Proteomics in the study of female fertility: an update4
MRMAssayDB: a comprehensive integrated resource for targeted proteomics assays3
Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?3
Genetic signatures of suicide attempt behavior: insights and applications3
Mapping the human sperm proteome – novel insights into reproductive research3
Single-cell omics techniques to elucidate cell-to-cell variability in signalling cascades involved in human diseases3
Metabolomics in cardiovascular diseases: from prevention strategies to domain-specific applications3
Blood plasma proteomic markers of Alzheimer’s disease, current status and application prospects3
A proteome-level view of brain tumors for a better understanding of novel diagnosis, prognosis, and therapy3
How can proteomics be incorporated into the management of atrial fibrillation?3
Metabolomics studies in cushing’s syndrome: recent developments and perspectives3
Proteolytic signaling in cancer3
Glycoproteomic contributions to hepatocellular carcinoma research: a 2023 update3
Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomics3
Toward real clinical utility: leveraging comprehensive cancer proteomic datasets for clinical insight3
AlphaFold and what is next: bridging functional, systems and structural biology3
How valuable can proteogenomics be in clinical breast cancer research?3
Immobilized metal ion affinity chromatography: waltz of metal ions and biomacromolecules3
Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancer3
Recent progress in quantitative phosphoproteomics3
Proteomics applications in next generation induced pluripotent stem cell models3
Proteomic scrutiny of nasal microbiomes: implications for the clinic2
An interview with William Cho2
Two decades of advances in sequence-based prediction of MoRFs, disorder-to-order transitioning binding regions2
Cellular thermal shift assay: an approach to identify and assess protein target engagement2
Spatial Proteomics towards cellular Resolution2
Proteomics and phosphoproteomics analysis of tissues for the reoccurrence prediction of colorectal cancer2
Empowering women and addressing underrepresentation in the field of mass spectrometry2
Protein biomarkers for radiation injury and testing of medical countermeasure efficacy: promises, pitfalls, and future directions2
HDL proteome: from its characterization to quantitative measurements in particle subspecies and functional associations2
Identifying therapeutic strategies for triple-negative breast cancer via phosphoproteomics2
Emerging protein sequencing technologies: proteomics without mass spectrometry?2
Proteomic technologies for profiling cell-membrane/secretome interactions in brain metastatic cancer progression2
Understanding the age-related alterations in the testis-specific proteome2
Schistosome proteomics: updates and clinical implications2
Proteomic approaches for untangling pharmacological targets in acute myelogenous leukemia2
0.17223882675171